CAS: 74204-00-5; 3-Bromo-5-Methylphenol

该化合物是一种溴化芳香化合物,其特点是氢氧基组和苯酚环上的甲基替代成分,其分子结构(C7H7BRO)在有机合成方面具有实用性,特别是作为制药,农用化学和特殊材料的中间体.溴原子为进一步功能化提供了回活动,而甲基组则在电子代用替代物中增强稳定性和影响再生选择性.该化合物的特点是其在有机溶剂中的中等溶性以及在标准条件下固态稳定性.其精确的溴化模式使得它对于建造复杂的分子结构,特别是作为关键脚手架的卤化苯醇的药化学中,具有价值.由于潜在的刺激性,适当处理是值得注意的.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号58169-99-6 2,3,4,6-Tetrabr... | CAS号591-17-3 3-溴甲苯 | CAS号29578-83-4 1-溴-3-甲氧基-5-甲苯 | CAS号14472-14-1 4-溴-3-甲基苯酚 | CAS号34946-83-3 2,4,4,6-tetrabr... | CAS号108-39-4 间甲酚 | CAS号4619-74-3 2,4,6-三溴-3-甲基苯酚 | CAS号74586-53-1 3-溴-5-甲基苯胺 | CAS号7446-70-0 氯化铝 | CAS号71-43-2 苯 | CAS号5367-32-8 3-甲基-4-硝基苯甲醚 | CAS号38512-82-2 5-甲基-2-硝基苯甲醚 | CAS号504-15-4 3,5-二羟基甲苯 | CAS号29578-83-4 1-溴-3-甲氧基-5-甲苯 | CAS号31601-41-9 2-乙酰氨基-5-甲氧基甲苯 | CAS号5345-42-6 3-甲基-2-硝基苯甲醚 | CAS号82994-17-0 3,7-dimethoxy-1... | CAS号89345-81-3 N-(2-甲氧基-4-甲基苯基)-乙酰胺 | CAS号90674-26-3 3-甲氧基-5-甲基苯甲醛 | CAS号59297-29-9 1-溴-3-(溴甲基)-5-甲氧基苯

合成工艺路线路线简述

    2,3,6-三溴对甲酚置于硫酸,氢碘酸,溴,溶剂黄146体系中,化学反应 4.12H,反应生成 3-溴-5-甲基苯酚
    参考文献:Brittain,Judith M.; Mare,Peter B. D. De La; Newman,Paul A.,Journal Of The Chemical Society. Perkin Transactions Ii,1981,P. 32-41
    标题:Brittain,Judith M.; Mare,Peter B. D. De La; Newman,Paul A.,Journal Of The Chemical Society. Perkin Transactions Ii,1981,P. 32-41

    海关参考信息

    专利信息


    专利号:US-6828466-B2
    优先权日:2002-07-19
    标题:Process for the synthesis of phenols from arenes
    发明人:MALECZKA JR ROBERT E; SMITH III MILTON R; HOLMES DANIEL; SHI FENG
    权利人:UNIV MICHIGAN STATE
    摘要:A process to synthesize substituted phenols such as those of the general formula RR'R''Ar(OH) wherein R, R', and R'' are each independently hydrogen or any group which does not interfere in the process for synthesizing the substituted phenol including, but not limited to, halo, alkyl, alkoxy, carboxylic ester, amine, amide; and Ar is any variety of aryl or hetroaryl by means of oxidation of substituted arylboronic esters is described. In particular, a metal-catalyzed C-H activation/borylation reaction is described, which when followed by direct oxidation in a single or separate reaction vessel affords phenols without the need for any intermediate manipulations. More particularly, a process wherein Ir-catalyzed borylation of arenes using pinacolborane (HBPin) followed by oxidation of the intermediate arylboronic ester by OXONE is described.

    专利号:US-12150934-B2
    优先权日:2016-11-30
    标 题 :Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases
    发明人:SIDDIQUI ARSHAD M; CIBLAT STEPHANE; CONSTANTINEAU-FORGET LEA; GRAND-MAITRE CHANTAL; GUO XIANGYU; SRIVASTAVA SANJAY; SHIPPS GERALD W; COOPER ALAN B; OZA VIBHA; KOSTURA MATTHEW W; LUTHER MICHAEL; LEVINE JEDD
    权利人:BANTAM PHARMACEUTICAL LLC
    摘要:Disclosed are methods of treating hyperproliferative disorders such as cancer, methods of arresting the cell cycle in cancer cells, methods of inhibiting glutathione synthesis in cancer cells, and associated compounds for use and uses in medicaments. In certain embodiments, the methods, uses and compounds are provided with reference to compounds of the structural formula (I), in which X1, X2, Z1, Z2, the ring system denoted by “aâ€?, R1, L1, L2, Q, L3, R3, L4, R4, L5, and R5 are as described herein. In certain embodiments, compounds disclosed herein are especially active against cancers having a mutant KRAS gene.

    专利号:US-2004030197-A1
    优先权日:2002-07-19
    标 题 :Process for the synthesis of phenols from arenes

    专利号:US-9550757-B2
    优先权日:2010-03-05
    标题:Nuclear transport modulators and uses thereof
    发明人:SHACHAM SHARON; KAUFFMAN MICHAEL; SANDANAYAKA VINCENT P; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to the field of nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to new substituted-heterocyclic azole compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity such as in treating cancer and other neoplastic disorders, inflammatory diseases, disorders of abnormal tissue growth and fibrosis including cardiomyopathy, pulmonary fibrosis, hepatic fibrosis, glomerulonephritis, and other renal disorders, and for the treatment of viral infections (both acute and chronic).
    珠海奥博凯生物医药技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aobchem.com.cn
    企业联系电话:15697568807👤
    📞珠海奥博凯生物医药技术有限公司 ⚠️参考联系方式
    联系人:赵金杰
    电话:15697568807
    手机:15697568807

    邮箱:zhao.jinjie@aobchem.com.cn
    通信地址: 广东省珠海市金湾区红旗镇珠海大道6698号美满车城1号楼东侧3楼
    邮编: 519090
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:广东省珠海市金湾区红旗镇珠海大道6698号美满车城1号楼东侧3楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/bf01521913
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知